We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Pierre Fabre Pharmaceuticals has joined a blockchain consortium that allows patients to share real-time digital health data to inform late-stage clinical research.